Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk
- PMID: 18560005
- DOI: 10.1001/jama.299.23.2777
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk
Abstract
Context: The importance of the cholesteryl ester transfer protein (CETP) pathway in coronary disease is uncertain. Study of CETP genotypes can help better understand the relevance of this pathway to lipid metabolism and disease risk.
Objective: To assess associations of CETP genotypes with CETP phenotypes, lipid levels, and coronary risk.
Data sources: Studies published between January 1970 and January 2008 were identified through computer-based and manual searches using MEDLINE, EMBASE, BIOSIS, Science Citation Index, and the Chinese National Knowledge Infrastructure Database. Previously unreported studies were sought through correspondence with investigators.
Study selection: Relevant studies related principally to 3 common (TaqIB [rs708272], I405V [rs5882], and -629C>A [rs1800775]) and 3 uncommon (D442G [rs2303790], -631C>A [rs1800776], and R451Q [rs1800777]) CETP polymorphisms.
Data extraction: Information on CETP genotypes, CETP phenotypes, lipid levels, coronary disease, and study characteristics was abstracted from publications, supplied by investigators, or both.
Results: Ninety-two studies had data on CETP phenotypes, lipid levels, or both in 113,833 healthy participants, and 46 studies had data on 27,196 coronary cases and 55,338 controls. For each A allele inherited, individuals with the TaqIB polymorphism had lower mean CETP mass (-9.7%; 95% confidence interval [CI], -11.7% to -7.8%), lower mean CETP activity (-8.6%; 95% CI, -13.0% to -4.1%), higher mean high-density lipoprotein cholesterol (HDL-C) concentrations (4.5%; 95% CI, 3.8%-5.2%), and higher mean apolipoprotein A-I concentrations (2.4%; 95% CI, 1.6%-3.2%). The pattern of findings was very similar with the I405V and -629C>A polymorphisms. The combined per-allele odds ratios (ORs) for coronary disease were 0.95 (95% CI, 0.92-0.99) for TaqIB, 0.94 (95% CI, 0.89-1.00) for I405V, and 0.95 (95% CI, 0.91-1.00) for -629C>A.
Conclusions: Three CETP genotypes that are associated with moderate inhibition of CETP activity (and, therefore, modestly higher HDL-C levels) show weakly inverse associations with coronary risk. The ORs for coronary disease were compatible with the expected reductions in risk for equivalent increases in HDL-C concentration in available prospective studies.
Comment in
-
CETP genes, metabolic effects, and coronary disease risk.JAMA. 2008 Jun 18;299(23):2795-6. doi: 10.1001/jama.299.23.2795. JAMA. 2008. PMID: 18560008 No abstract available.
Similar articles
-
Common variants of Cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population.Clin Chim Acta. 2007 Jan;375(1-2):140-6. doi: 10.1016/j.cca.2006.06.031. Epub 2006 Jul 1. Clin Chim Acta. 2007. PMID: 16890925
-
Cholesteryl ester transfer protein TaqIB, -629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population.Clin Chim Acta. 2009 Apr;402(1-2):139-45. doi: 10.1016/j.cca.2008.12.041. Epub 2009 Jan 12. Clin Chim Acta. 2009. PMID: 19168039
-
I405V and -629C/A polymorphisms of the cholesteryl ester transfer protein gene in patients with coronary artery disease.Iran Biomed J. 2009 Apr;13(2):103-8. Iran Biomed J. 2009. PMID: 19471550
-
Association of apolipoprotein E genotypes with lipid levels and coronary risk.JAMA. 2007 Sep 19;298(11):1300-11. doi: 10.1001/jama.298.11.1300. JAMA. 2007. PMID: 17878422 Review.
-
Associations of Cholesteryl Ester Transfer Protein TaqIB Polymorphism with the Composite Ischemic Cardiovascular Disease Risk and HDL-C Concentrations: A Meta-Analysis.Int J Environ Res Public Health. 2016 Sep 5;13(9):882. doi: 10.3390/ijerph13090882. Int J Environ Res Public Health. 2016. PMID: 27608031 Free PMC article. Review.
Cited by
-
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.J Lipid Res. 2012 Mar;53(3):556-560. doi: 10.1194/jlr.M020404. Epub 2012 Jan 11. J Lipid Res. 2012. PMID: 22236405 Free PMC article. Clinical Trial.
-
CETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials.J Lipid Res. 2015 Mar;56(3):713-721. doi: 10.1194/jlr.P055715. Epub 2014 Dec 29. J Lipid Res. 2015. PMID: 25548261 Free PMC article. Clinical Trial.
-
Prevention of fatal hepatic complication in schistosomiasis by inhibition of CETP.J Biomed Res. 2015 May;29(3):176-88. doi: 10.7555/JBR.29.20150005. Epub 2015 Apr 15. J Biomed Res. 2015. PMID: 26060442 Free PMC article. Review.
-
Interaction between CETP Taq1B polymorphism and dietary patterns on lipid profile and severity of coronary arteries stenosis in patients under coronary angiography: a cross-sectional study.Nutr J. 2023 Dec 14;22(1):70. doi: 10.1186/s12937-023-00899-w. Nutr J. 2023. PMID: 38098040 Free PMC article.
-
Genetics of HDL-C: a causal link to atherosclerosis?Curr Atheroscler Rep. 2013 Jun;15(6):326. doi: 10.1007/s11883-013-0326-8. Curr Atheroscler Rep. 2013. PMID: 23591671 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources